INMD(INMD)
INMD
Q4 2026 EPS Estimate
$0.32
Oct 28, 2026 · Reports before open
Revenue Estimate
$92M
FY2026E EPS$1.31
FY2027E EPS$1.41
Analyst Sentiment
Wall St. Consensus
Hold11 analysts·Moderate coverage
61
Score
5 Buy (45%)6 Hold (55%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
545%
Hold
655%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$19.00
+26.5%
Consensus
$19.00
+26.5%
Bull
$19.00
+26.5%
12-Month Target Range11 analysts
$19.00$19.00$19.00
Current $15.02Consensus
Current Price
$15.02
Upside to Consensus
$3.98
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+2.08%
EPS+7.50%
FY2028
Rev+2.92%
EPS+5.75%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $370M | $378M | $389M |
| Low | $364M | $368M | $375M |
| High | $374M | $383M | $397M |
| EBITDA Avg | $150M | $153M | $157M |
| Low | $147M | $149M | $152M |
| High | $151M | $155M | $161M |
| EBIT Avg | $149M | $152M | $157M |
| Low | $147M | $148M | $151M |
| High | $151M | $154M | $160M |
| Net Income Avg | $85M | $84M | $88M |
| Low | $84M | $79M | $77M |
| High | $87M | $100M | $116M |
| EPS Avg | $1.31 | $1.41 | $1.49 |
| Low | $1.28 | $1.21 | $1.17 |
| High | $1.33 | $1.53 | $1.77 |
| Analysts (Rev / EPS) | 4 / 2 | 6 / 5 | 4 / 4 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $92M | $101M | $83M | $97M | $94M | $104M | $84M | $100M |
| Low | $88M | $99M | $80M | $95M | $91M | $102M | $82M | $98M |
| High | $94M | $104M | $85M | $100M | $96M | $107M | $87M | $103M |
| EBITDA Avg | $37M | $41M | $33M | $39M | $38M | $42M | $34M | $41M |
| Low | $36M | $40M | $33M | $38M | $37M | $41M | $33M | $40M |
| High | $38M | $42M | $34M | $41M | $39M | $43M | $35M | $42M |
| EBIT Avg | $37M | $41M | $33M | $39M | $38M | $42M | $34M | $41M |
| Low | $36M | $40M | $32M | $38M | $37M | $41M | $33M | $39M |
| High | $38M | $42M | $34M | $40M | $39M | $43M | $35M | $42M |
| Net Income Avg | $20M | $23M | $17M | $21M | $21M | $24M | $17M | $22M |
| Low | $18M | $23M | $16M | $20M | $20M | $23M | $17M | $21M |
| High | $21M | $23M | $17M | $21M | $22M | $25M | $18M | $22M |
| EPS Avg | $0.33 | $0.39 | $0.28 | $0.35 | $0.36 | $0.41 | $0.29 | $0.37 |
| Low | $0.30 | $0.38 | $0.27 | $0.33 | $0.35 | $0.39 | $0.28 | $0.35 |
| High | $0.36 | $0.39 | $0.29 | $0.36 | $0.37 | $0.42 | $0.30 | $0.38 |
| Analysts (Rev / EPS) | 5 / 3 | 5 / 3 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 2 | 3 / 2 |